Kaczynski MM, Zureikat RM, Kaczynski MR et al. · Biomedicines · PMID 42792699
From the original abstract
“Dedicated randomized controlled trials are needed to determine the efficacy and safety of retatrutide in patients with schizophrenia spectrum disorders receiving clozapine or olanzapine.”
From the closing sentence of the indexed abstract. This is a short quotation from the authors, not a full study appraisal.
Read the full abstract & conclusionThis paper brings together existing research. Its conclusions depend on the included studies and their methods; it is not a separate treatment trial.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to Retatrutide studies